Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Inv. presentation
Acq. announced
Director departure
Appointed director
|
|
Emmaus Life Sciences, Inc. (MYND)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| LEE WILLIS C (COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 750 shares
@ $0.28, valued at
$210
Bought 28,700 shares
@ $0.29, valued at
$8.3k
|
|
| 01/20/2023 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,000,000 options to buy
@ $0.5, valued at
$1M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Granted 7,500,000 warrants
@ $4.5, valued at
$33.8M
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 62,500 shares
@ $0.18, valued at
$11.3k
Bought 35,000 shares
@ $0.17, valued at
$6k
|
|
| 10/13/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,000 shares
@ $0.09, valued at
$450
Bought 160,000 shares
@ $0.08, valued at
$12.8k
|
|
| 10/12/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,000 shares
@ $0.2, valued at
$1.2k
Bought 5,000 shares
@ $0.2, valued at
$1k
Bought 10,000 shares
@ $0.2, valued at
$2k
Bought 5,000 shares
@ $0.16, valued at
$800
Bought 10,000 shares
@ $0.15, valued at
$1.5k
Bought 5,000 shares
@ $0.15, valued at
$750
Bought 4,000 shares
@ $0.13, valued at
$520
Bought 10,000 shares
@ $0.09, valued at
$900
Bought 130,000 shares
@ $0.09, valued at
$11.7k
|
|
| 07/25/2022 |
4
| LEE WILLIS C (COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 3,200 shares
@ $0.39, valued at
$1.2k
|
|
| 06/03/2022 |
4
| LEE WILLIS C (Director & COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,500 shares
@ $0.37, valued at
$925
Bought 2,500 shares
@ $0.4, valued at
$1k
|
|
| 06/02/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,000 shares
@ $0.49, valued at
$2.5k
Bought 2,000 shares
@ $0.5, valued at
$1k
|
|
| 05/19/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,000 shares
@ $0.6, valued at
$3.6k
Bought 10,000 shares
@ $0.34, valued at
$3.4k
Bought 7,351 shares
@ $0.35, valued at
$2.6k
|
|
| 04/12/2022 |
4
| LEE WILLIS C (Director & COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 3,200 shares
@ $0.98, valued at
$3.1k
Bought 1,400 shares
@ $0.95, valued at
$1.3k
Bought 1,600 shares
@ $0.76, valued at
$1.2k
Bought 8,900 shares
@ $0.88, valued at
$7.8k
|
|
| 03/02/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 53,800 shares
@ $1.49, valued at
$80.2k
|
|
| 02/28/2022 |
4
| LEE WILLIS C (Vice Chairman & COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 500 shares
@ $1.42, valued at
$710
Bought 5,900 shares
@ $1.44, valued at
$8.5k
Bought 7,200 shares
@ $1.51, valued at
$10.9k
Bought 6,600 shares
@ $1.5, valued at
$9.9k
Bought 900 shares
@ $1.65, valued at
$1.5k
|
|
| 02/28/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 11,000 shares
@ $1.43, valued at
$15.7k
Bought 5,500 shares
@ $1.41, valued at
$7.8k
|
|
| 02/23/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,500 shares
@ $1.43, valued at
$2.1k
Bought 17,800 shares
@ $1.44, valued at
$25.6k
|
|
| 02/18/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 1,000 shares
@ $1.47, valued at
$1.5k
Bought 6,500 shares
@ $1.43, valued at
$9.3k
|
|
| 02/16/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,000 shares
@ $1.45, valued at
$8.7k
Bought 6,000 shares
@ $1.45, valued at
$8.7k
|
|
| 02/11/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 23,500 shares
@ $1.45, valued at
$34.1k
Bought 3,000 shares
@ $1.45, valued at
$4.4k
Bought 4,000 shares
@ $1.49, valued at
$6k
|
|
| 02/09/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,250 shares
@ $1.47, valued at
$7.7k
Bought 3,250 shares
@ $1.49, valued at
$4.8k
|
|
| 02/07/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 6,250 shares
@ $1.4, valued at
$8.8k
Bought 7,000 shares
@ $1.43, valued at
$10k
|
|
| 01/05/2022 |
4
| Lui Alfred Fu Kong (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 10,000 shares
@ $1.58, valued at
$15.8k
|
|
| 01/05/2022 |
4
| LEE WILLIS C (Vice Chairman & COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 500 shares
@ $1.54, valued at
$770
Bought 200 shares
@ $1.74, valued at
$348
Bought 500 shares
@ $1.52, valued at
$760
Bought 500 shares
@ $1.5, valued at
$750 |
|
|
|
|